TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Oncology Biomarker Market Accelerates Toward USD 113.5 Billion by 2034

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Towards Healthcare
Oncology Biomarker Market Accelerates Toward USD 113.5 Billion by 2034

The global oncology biomarker market is projected to grow from USD 34.16 billion in 2024 to USD 113.54 billion by 2034, with a 12.73% CAGR, driven by precision medicine, technological advances, and increasing cancer incidence.

Insights
RHHBY   positive

Highlighted as a key player across multiple value chain segments with strong R&D, clinical trials, and patient support capabilities